12 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/28/25 15:31
3/26/25
ADVMHealthBioPrdBiological Products, (No DiagLeonard Braden MichaelINTP.am1895.1103712,865D
4/28/25 15:24
3/26/25
ADVMHealthBioPrdBiological Products, (No DiagLeonard Braden MichaelINTP.m1895.1103712,865D
4/24/25 09:35
4/22/25
ADVMHealthBioPrdBiological Products, (No DiagLeonard Braden MichaelINTP.m1,0493.000350123,249M
4/2/25 18:07
3/31/25
ADVMHealthBioPrdBiological Products, (No DiagLeonard Braden MichaelINTP.m1474.2303515,642I
3/27/25 19:06
3/26/25
ADVMHealthBioPrdBiological Products, (No DiagLeonard Braden MichaelINTP.m1895.1103712,865D
3/20/25 20:02
3/18/25
ADVMHealthBioPrdBiological Products, (No DiagLeonard Braden MichaelINTP.m5884.98011825,520I
2/28/25 16:04
2/26/25
ADVMHealthBioPrdBiological Products, (No DiagLeonard Braden MichaelINTP.m1,4394.270337142,710I
7/31/24 16:19
7/30/24
ADVMHealthBioPrdBiological Products, (No DiagLeonard Braden MichaelINTP6137.1508642,373I
7/18/24 21:16
7/17/24
ADVMHealthBioPrdBiological Products, (No DiagLeonard Braden MichaelINTP.m1,7868.260216102,287I
2/9/24 17:51
2/7/24
ADVMHealthBioPrdBiological Products, (No DiagScopa James PaulCADP1351.350100999%103D
2/9/24 17:50
2/7/24
ADVMHealthBioPrdBiological Products, (No DiagLupher, Jr. Mark L.CADP1761.350130New130D
6/9/23 16:26
6/7/23
ADVMHealthBioPrdBiological Products, (No DiagRubinstein Linda MCAOCFOP1451.450100New100D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact